Description
Target Evaluation for Drug Discovery: Pre-Scoped Standard Evaluation
This service evaluates customer-selected targets for drug discovery in the biopharmaceutical industry.
This pre-scoped service offers predefined packages (basic, standard and premium) with clear pricing, timelines, and deliverables, allowing clients to purchase services with minimal project management overhead. This pre-defined nature makes it easy for clients to purchase services quickly, without the need for extensive communication or negotiation. To amend the standardized services by client specific needs, please contact us before placing the order.
This service is related to the evaluation of targets for drug discovery. If you are interested in using this service, just add the target of choice when placing the order and send as much background information as found useful (e.g. what kind of drug modality is of special interest, or which alternative target should be kept in mind etc).
The evaluation of customer-selected targets for drug discovery is conducted by Ulrich Martin, a physician specializing in pharmacology with long-standing experience in research and development of biological product candidates in the pharmaceutical and biotech industry. He has a proven track record in publishing reports about competitor analysis, target evaluation, drug profiling, technology assessment and analyzing terms of partnering deals (see recent reports at https://lamerie.com/reports/ ).
